Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Evofem Biosciences, Inc.
OTC:EVFMHealthcare · Biotechnology
-2.99%$0.0065
Mkt Cap$861K
Float132.53M
O/S132.53M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$20.18M
Net Income$391K
Total Assets$20.27M
Free Cash Flow-$2M
Debt & Equity
Total Debt$54.55M
Total Equity-$69.44M
Preferred Stock$4.9M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:125Reverse splitMay 18, 2023125 shares → 1
- 1:15Reverse splitMay 6, 202215 shares → 1
Balance Sheet Details
Assets$20.27M
Liabilities$89.71M
Accounts Receivable$12.48M
Accounts Payable$13.15M
Inventory$1.13M
PP&E (Net)$600K
Goodwill$0
Intangible Assets$4.35M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $20.18M | $19.36M | $18.22M | $16.84M | $8.24M | $446K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $100K |
| YoY Growth | 4.2% | 6.3% | 8.2% | 104.2% | 1748.4% | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $5.12M | $3.83M | $6.51M | $4.42M | $4.05M | $1.65M | $905K | $262K | $244K | $69K | $58K | $18K | $72K | $100K |
| Gross Profit | $15.07M | $15.53M | $11.71M | $12.42M | $4.19M | -$1.2M | -$905K | -$262K | -$244K | -$69K | -$58K | -$18K | -$72K | $0 |
| Gross Margin | 74.7% | 80.2% | 64.3% | 73.8% | 50.8% | -269.7% | - | - | - | - | - | - | - | - |
| Research and Development | $3.45M | $1.84M | $2.94M | $25.03M | $33.13M | $17.05M | $22.23M | $43.41M | $23.54M | $6.58M | $34.41M | $5.17M | $11.45M | $3.25M |
| Selling, General, and Administrative | $17.07M | $20.74M | $26.61M | $71.51M | $137.86M | $85.37M | $29.61M | $33.97M | $11.9M | $5.39M | $7.58M | $4.4M | $2.9M | $2.47M |
| Other | -$6.89M | $619K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $13.63M | $23.2M | $29.55M | $96.55M | $170.99M | $102.42M | $51.84M | $77.38M | $35.44M | $11.97M | $41.99M | $9.57M | $14.35M | $5.72M |
| Operating Income (EBIT) | $1.44M | -$7.68M | -$17.85M | -$84.12M | -$166.8M | -$103.62M | -$52.74M | -$77.64M | -$35.69M | -$12.04M | -$42.05M | -$9.59M | -$14.42M | -$5.74M |
| Operating Margin | 7.1% | -39.6% | -98.0% | -499.6% | -2023.3% | -23234.1% | - | - | - | - | - | - | - | -5741.0% |
| Interest Expense | $2.63M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.04M | $1.13M | $375K | $57K | $937K |
| Interest Income | $15K | $16K | $31K | $85K | $15K | $169K | $458K | $127K | $128K | $59K | $26K | $8K | $1K | $2K |
| Other Income (Expense) | -$1.05M | -$1.18M | $70.84M | $7.47M | -$38.37M | -$38.68M | -$27.29M | -$48.07M | -$69.61M | -$976K | -$1.11M | -$1.23M | -$594K | -$2.09M |
| Income Before Tax (EBT) | $393K | -$8.86M | $53M | -$76.65M | -$205.18M | -$142.31M | -$80.03M | -$125.71M | -$105.3M | -$13.02M | -$43.16M | -$10.82M | -$15.02M | -$7.83M |
| Income Tax Expense | $2K | $0 | $17K | $44K | $17K | $4K | $4K | $2K | $3K | $0 | $0 | $0 | $0 | $0 |
| Net Income | $391K | -$8.86M | $52.98M | -$76.7M | -$205.19M | -$142.31M | -$80.03M | -$125.71M | -$105.31M | -$13.02M | -$43.16M | -$10.82M | -$15.02M | -$7.83M |
| Net Income Margin | 1.9% | -45.8% | 290.8% | -455.5% | -2489.0% | -31907.8% | - | - | - | - | - | - | - | -7827.6% |
| Supplementary Data | ||||||||||||||
| EPS | 0.00 | -0.09 | 10.36 | -164.59 | -2962.49 | -3973.23 | -3730.27 | -10763.01 | -85613.82 | -10612.22 | -35449.44 | -8690.15 | -11798.92 | -6150.50 |
| Diluted EPS | 0.00 | -0.09 | 0.05 | -164.59 | -2962.49 | -3973.23 | -3730.27 | -10763.01 | -85613.82 | -10612.22 | -35449.44 | -8690.15 | -11798.92 | -6150.50 |
| Weighted Average OS | 123.66M | 96.46M | 4.83M | 465,984 | 69,818 | 35,817 | 21,455 | 11,680 | 1,230 | 1,227 | 1,217 | 1,245 | 1,273 | 1,273 |
| EBITDA | $2.06M | -$6.92M | -$16.07M | -$82.08M | -$165.78M | -$141.12M | -$79.12M | -$125.45M | -$105.06M | -$11.91M | -$41.96M | -$10.43M | -$14.89M | -$6.77M |
| EBITDA Margin | 10.2% | -35.7% | -88.2% | -487.5% | -2010.9% | -31642.2% | - | - | - | - | - | - | - | -6767.4% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $578K | $741K | $580K | $2.77M | $7.73M | $71.45M | $15.88M | $1.33M | $1.21M | $11.48M | $37.75M | $75.95M | $4.36M | $11.1M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $8.23M | $431K | $490K | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $578K | $741K | $580K | $2.77M | $7.73M | $71.45M | $24.11M | $1.76M | $1.7M | $11.48M | $37.75M | $75.95M | $4.36M | $11.1M |
| Accounts Receivable | $12.48M | $9.83M | $5.74M | $1.13M | $6.45M | $1.32M | $686K | $316K | $313K | $0 | $0 | $0 | $0 | $0 |
| Inventory | $1.13M | $1.58M | $1.7M | $5.38M | $7.67M | $7.16M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $661K | $1.07M | $418K | $1.64M | $5.68M | $16.52M | $655K | $401K | $340K | $1.03M | $1.98M | $926K | $142K | $1.48M |
| Total Current Assets | $15.28M | $13.61M | $9.21M | $12.7M | $30.14M | $97.73M | $26.42M | $2.48M | $2.35M | $12.51M | $39.73M | $76.87M | $4.51M | $12.58M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $600K | $547K | $1.31M | $8.35M | $11.17M | $11.19M | $554K | $593K | $848K | $109K | $186K | $25K | $24K | $197K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $4.35M | $9.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $800K | $800K | $800K | $250K | $500K | $750K | $200K | $200K | $0 | $0 | $40K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $42K | $36K | $35K | $3.32M | $403K | $248K | $1.07M | $439K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $4.99M | $10.18M | $1.34M | $12.46M | $12.37M | $12.24M | $1.87M | $1.53M | $1.6M | $309K | $386K | $25K | $24K | $237K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $20.27M | $23.79M | $10.55M | $25.16M | $42.51M | $109.97M | $28.3M | $4.01M | $3.95M | $12.82M | $40.11M | $76.9M | $4.53M | $12.82M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $13.15M | $16.17M | $17.02M | $14.98M | $10.32M | $10.64M | $6.01M | $8.88M | $9M | $0 | $4.02M | $997K | $644K | $700K |
| Short-Term Debt | $54.37M | $45.88M | $43.27M | $65.68M | $108.93M | $54.7M | $197K | $4.01M | $0 | $0 | $2.76M | $0 | $207K | $628K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $402K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $14.18M | $12.81M | $7.85M | $6.73M | $7.72M | $5.43M | $2.78M | $11.51M | $91.96M | $902K | $2.33M | $912K | $678K | $580K |
| Total Current Liabilities | $84.82M | $80.45M | $72.46M | $93.83M | $137.66M | $77.28M | $12.66M | $27.33M | $103.35M | $902K | $9.1M | $1.91M | $1.53M | $1.91M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $25.21M | $0 | $0 | $0 | $0 | $7.21M | $9.74M | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $4.84M | $9.81M | $4.59M | $0 | $0 | $97K | $0 | $37K | $280K | $0 | $0 | $0 | $2.2M | $1.62M |
| Total Long-Term Liabilities | $4.89M | $14.6M | $4.6M | $3.13M | $4.42M | $31.34M | $0 | $37K | $280K | $0 | $7.21M | $9.74M | $2.2M | $1.62M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $89.71M | $95.05M | $77.06M | $96.96M | $142.09M | $108.62M | $12.66M | $27.37M | $103.63M | $902K | $16.3M | $11.65M | $3.73M | $3.53M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $4.9M | $0 | $0 | $0 | $4.74M | $0 | $0 | $0 | $189.87M | $0 | $0 | $0 | $57.49M | $51.05M |
| Common Stock | $13K | $11K | $2K | $12K | $16K | $8K | $5K | $3K | $0 | $1K | $1K | $1K | $51 | $51 |
| Retained Earnings | -$897.39M | -$897.66M | -$888.7M | -$938.69M | -$860.68M | -$655.49M | -$513.18M | -$433.15M | -$307.28M | -$125.85M | -$112.83M | -$69.67M | -$58.86M | -$43.84M |
| Comprehensive Income & Other | -$8.82M | -$2.63M | -$849K | $49.53M | $5.09M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $827.94M | $826.4M | $822.19M | $866.88M | $761.09M | $656.83M | $528.81M | $409.79M | $207.6M | $137.76M | $136.64M | $134.92M | $59.65M | $53.14M |
| Total Equity | -$69.44M | -$71.26M | -$66.51M | -$71.8M | -$99.58M | $1.35M | $15.64M | -$23.36M | -$99.67M | $11.91M | $23.81M | $65.25M | $797K | $9.3M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $20.27M | $23.79M | $10.55M | $25.16M | $42.51M | $109.97M | $28.3M | $4.01M | $3.95M | $12.82M | $40.11M | $76.9M | $4.53M | $12.82M |
| Supplementary Data | ||||||||||||||
| Total Debt | $54.55M | $45.97M | $43.37M | $71.13M | $115.68M | $85.94M | $197K | $4.01M | $0 | $0 | $9.96M | $9.74M | $207K | $628K |
| Net Debt | $53.97M | $45.97M | $43.37M | $68.36M | $107.95M | $14.49M | -$15.68M | $2.68M | -$1.21M | -$11.48M | -$27.79M | -$66.21M | -$4.16M | -$10.47M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | $274K | -$8.86M | $52.98M | -$76.7M | -$205.19M | -$142.31M | -$80.03M | -$125.71M | -$105.31M | -$13.02M | -$43.16M | -$10.82M | -$15.02M | -$7.83M |
| Depreciation & Amortization | $626K | $756K | $1.78M | $2.05M | $1.02M | $1.18M | $905K | $262K | $244K | $69K | $58K | $18K | $72K | $124K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $166K | $847K | $1.19M | $3.31M | $8.9M | $0 | $0 | $17.84M | $861K | $0 | $1.58M | $613K | $80K | $122K |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | -$2.65M | -$4.09M | -$4.61M | $5.32M | -$5.38M | -$1.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | -$260K | $57K | $2.11M | $1.57M | -$21K | -$6.01M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $182K | -$910K | $4.09M | $4.47M | -$4K | $4.13M | -$2.93M | $3.8M | $7.05M | $0 | $4.43M | $455K | $51K | -$493K |
| Other Working Capital | $3.31M | $5.81M | $3.14M | -$5.34M | $15.98M | -$12.28M | -$9.74M | -$741K | $8.21M | -$4.49M | -$1.05M | -$784K | $1.34M | -$1.35M |
| Total Working Capital Change | $583K | $867K | $4.73M | $6.02M | $10.58M | -$15.23M | -$12.67M | $3.06M | $15.26M | -$4.49M | $3.38M | -$329K | $1.39M | -$1.84M |
| Other Non-Cash Items | -$3.64M | $2.5M | -$69.64M | -$5.09M | $38.03M | $50.47M | $35.42M | $48.05M | $69.7M | $1.19M | $227K | $945K | $565K | $2.03M |
| Net Cash from Operating | -$1.99M | -$3.88M | -$8.97M | -$70.41M | -$146.67M | -$105.89M | -$56.38M | -$56.5M | -$19.24M | -$16.25M | -$37.91M | -$9.57M | -$12.9M | -$7.4M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$5K | -$14K | -$4K | -$341K | -$2.94M | -$2.25M | -$164K | -$7K | -$6K | $0 | -$226K | -$18K | -$21K | $0 |
| Acquisitions | -$57K | -$555K | $0 | $0 | $250K | $250K | $282K | $2.15M | $250K | $3K | $0 | $0 | $64K | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | -$8.23M | $0 | $0 | $0 | -$200K | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $8.23M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $40K | $0 |
| Net Cash from Investing | -$62K | -$569K | -$4K | -$341K | -$2.69M | $6.23M | -$8.12M | $2.14M | $244K | $3K | -$426K | -$18K | $83K | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | -$4.49M | -$5.61M | - | -$50M | - | - | - | $10.05M | - | -$9.79M | $448K | -$2.43M |
| Common Stock Issuance | $0 | $5M | $0 | $32.32M | $81.53M | $107.97M | $84.94M | $56.17M | -$713K | $34K | $139K | $71.38M | $6.53M | $10.24M |
| Common Stock Repurchases | $0 | $0 | $0 | -$18K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $105K | $0 | $290K | $24.03M | -$841K | -$2.68M | -$1.57M | -$1.59M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $1.89M | $4.62M | $4.78M | $61.94M | $90.69M | $155.29M | $79.36M | $54.42M | $9.21M | -$10.02M | $139K | $81.17M | $6.09M | $12.67M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$163K | $161K | -$4.2M | -$8.81M | -$58.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$1.99M | -$3.88M | -$8.97M | -$70.41M | -$146.67M | -$105.89M | -$56.38M | -$56.5M | -$19.24M | -$16.25M | -$37.91M | -$9.57M | -$12.9M | -$7.4M |
| Capital Expenditure | -$5K | -$14K | -$4K | -$341K | -$2.94M | -$2.25M | -$164K | -$7K | -$6K | $3 | -$226K | -$18K | -$21K | $0 |
| Free Cash Flow | -$2M | -$3.9M | -$8.97M | -$70.75M | -$149.61M | -$108.14M | -$56.55M | -$56.51M | -$19.25M | -$16.25M | -$38.14M | -$9.59M | -$12.93M | -$7.4M |
| Cash at Beginning | $741K | $580K | $4.78M | $13.59M | $72.25M | $15.88M | $1.33M | $1.21M | $11.48M | $37.75M | $75.95M | $4.36M | $11.1M | $0 |
| Cash at End | $578K | $741K | $580K | $4.78M | $13.59M | $71.45M | $15.88M | $1.33M | $1.21M | $11.48M | $37.75M | $75.95M | $4.36M | $11.1M |